Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics.
Camire RM.
J Thromb Thrombolysis. 2021 Aug;52(2):383-390. doi: 10.1007/s11239-021-02456-w. Epub 2021 Apr 22.
Blood coagulation factor VIII: An overview.
Bhopale GM, Nanda RK.
J Biosci. 2003 Dec;28(6):783-9. doi: 10.1007/BF02708439.
Hemophilic arthropathy: Current knowledge and future perspectives.
Gualtierotti R, Solimeno LP, Peyvandi F.
J Thromb Haemost. 2021 Sep;19(9):2112-2121. doi: 10.1111/jth.15444. Epub 2021 Jul 27.
Haemophilias A and B.
Bolton-Maggs PH, Pasi KJ.
Lancet. 2003 May 24;361(9371):1801-9. doi: 10.1016/S0140-6736(03)13405-8.
Coagulation Testing in the Core Laboratory.
Winter WE, Flax SD, Harris NS.
Lab Med. 2017 Nov 8;48(4):295-313. doi: 10.1093/labmed/lmx050.
Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms.
Biswas A, Ivaskevicius V, Thomas A, Oldenburg J.
Hamostaseologie. 2014;34(2):160-6. doi: 10.5482/HAMO-13-08-0046. Epub 2014 Feb 7.
An overview of inherited factor VII deficiency.
Robinson KS.
Transfus Apher Sci. 2019 Oct;58(5):569-571. doi: 10.1016/j.transci.2019.08.006. Epub 2019 Aug 6.
Nijmegen-Bethesda assay to measure factor VIII inhibitors.
Duncan E, Collecutt M, Street A.
Methods Mol Biol. 2013;992:321-33. doi: 10.1007/978-1-62703-339-8_24.
Rare bleeding disorders: Advances in management.
Casini A, Al-Samkari H, Hayward C, Peyvandi F.
Haemophilia. 2024 Apr;30 Suppl 3:60-69. doi: 10.1111/hae.14986. Epub 2024 Mar 18.
Uncertain thrombophilia markers.
Franchini M, Martinelli I, Mannucci PM.
Thromb Haemost. 2016 Jan;115(1):25-30. doi: 10.1160/TH15-06-0478. Epub 2015 Aug 13.
